Business Wire

Innovative IoT Modem Card From Thales Makes It Easier to Build a 5G World of Trust

Share

Thales announces the new Cinterion® MV32 modem card that makes it quicker and easier for manufacturers to build and maintain resilient, high-performance 5G devices that will transform everyday life in the years ahead. Harnessing the full potential of 5G Mobile Broadband connectivity, the new modem card is designed to be at the heart of a wide array of demanding IoT (Internet of Things) use cases, such as securely connecting enterprises, remote patient care and intelligent monitoring of renewable energy generation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220522005024/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Thales 5G IoT (Graphic: Thales)

Effortlessly connecting 5G networks and next-gen IoT devices

The 5G roll-out will not only bring unprecedented mobile broadband speed to billions of people worldwide. It also offers an extraordinary leap in the sheer number of devices that cellular networks can support. Connectivity will be enabled for billions more machines. As a result, 5G is laying the foundations for vast new fleets of permanently connected IoT devices that enable a more sustainable and trustworthy future for us all.

Many of these new IoT devices will be highly compact. Thales’ space-saving 5G modem card therefore represents the ideal partner for the tiny embedded SIMs (eSIMs) that are another key building block for effortless connectivity. Next-generation IoT applications will demand the always-on, ultra-high speed connectivity and exceptional reliability that characterises the new Cinterion MV32 modem card:

  • Extensively leverages Thales’ broad expertise in providing successful 5G IoT solutions that manage connectivity plans in the field, enabling seamless, go-anywhere 5G.
  • Reliably delivers superior 5G cellular performance, thanks to industry’s most advanced and optimized radio frequency design, to enable the ultra-high speed and low latency.1

Protecting against a new wave of cyber-threats

For all its benefits, the distributed, virtualized, software-based design of many 5G networks also brings with it new vulnerabilities to cyber-attack. In response, the Cinterion MV32 5G modem card embodies Thales’ unrivalled expertise and experience in bringing robust security and protection to the 5G domain:

  • Leverages Thales’ security-by-design philosophy and core expertise in robust cyber-protection – enabling dynamic protection of devices in the field and over the entire lifecycle through secure remote updates.
  • Stringently and continuously penetration-tested by independent security experts.

“We were able to be a first-mover in 5G branch networking devices, in part because Thales provided a great globally-certified solution with support to a wide variety of frequency bands. They also provided responsive support to our engineers and have been a reliable supplier even when everything else is in shortage. We look forward to deploying Thales’ next-gen 5G SA MV32 into our devices in the coming year.” Keith Chau, general manager, Peplink

“For our customers, the latest generation MV32 5G modem card represents just the right product at the right time. Manufacturers worldwide must look at 5G to enable revolutionary new IoT solutions that will touch every aspect of our lives. Our new solution makes it a cinch to embed this ultra-fast connectivity. There is no trade-off between speed, latency, reliability and cyber-protection: the compact MV32 delivers them all.” Thierry Uguen, Director Product Management IoT at Thales

1Further technical annotations:

  • The new Cinterion 5G data card leverages the industry-standard M.2 form factor for easy plug-and-play as well as the latest 3GPP Release 16 enhanced Mobile Broadband (eMBB) standard for peak performance.
  • It consistently supports the highest levels of data throughput without overheating as a result of its sophisticated thermal design.
  • Its radio frequency design also reduces complexity and increases reliability allowing the device to tap into the highest performance grade on the field, by leveraging the latest network deployments.

To learn more, join one of our virtual launch events on May 24 at 9:00 AM or 5:00 PM.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.

Thales has 81,000 employees in 68 countries. In 2021, the Group generated sales of €16.2 billion.

PLEASE VISIT
Thales Group
Digital Identity & Security and Thales MV32 modem card
@Thalesgroup

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS
Thales, Media Relations
Digital Identity and Security
Vanessa Viala
+33 (0)6 07 34 00 34
vanessa.viala@thalesgroup.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye